Abby Med Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Abby Med General Information


Operator of a biotechnology company intended to develop a novel class of cancer drugs targeting malignant gliomas. The company engages in developing personalized cancer therapies to fight malignant gliomas using triphenylmethanes which are effective against human glioma cell lines, enabling physicians to offer effective chemotherapeutic treatments and improve survival outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 571 Pelham Road North East
  • Atlanta, GA 30324
  • United States
+1 (404) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abby Med Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Nov-2022 000 Completed Startup
2. Grant 23-Oct-2014 00000 000 Completed Startup
1. Seed Round 15-Jan-2014 $1M $1M Completed Startup
To view Abby Med’s complete valuation and funding history, request access »

Abby Med Executive Team (2)

Name Title Board Seat Contact Info
Jack Arbiser Ph.D Co-Founder
You’re viewing 1 of 2 executive team members. Get the full list »

Abby Med Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Emory University Department of Human Genetics Corporation 000 0000 000000 0
To view Abby Med’s complete investors history, request access »